PET/CT Imaging in COVID-19 Patients

• Status: Enrolling by invitation
• Trial end date: 2022-05-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a PET/CT study using the 18F-αvβ6-binding-peptide.The goal of this study is to evaluate this peptide in patients after infection with SARS CoV2.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of California, Davis

Criteria

Inclusion Criteria:

• Men and women age ≥ 18 yrs

• Diagnosed with SARS CoV2

• Must have 2 sequential COVID negative tests prior to each scan

• Must have no previous lung disease prior to SARS CoV2 infection

• Lung image (Xray or CT) taken during infectious/ diagnosis period

• Will sign the IRB-approved consent form

• Able to remain motionless for up to 30-60 minutes per scan.

Exclusion Criteria:

• Life expectancy <3 mo

• Women who are pregnant or breast-feeding

• Patients who cannot undergo PET/CT scanning because of weight limits(>350lbs)

• Lack of availability for follow-up assessments

• Re-infection with SARS CoV2 between scan sessions

• Other active infectious respiratory illness